Marie-Louise Fjaellskog
Director/Board Member chez FARON PHARMACEUTICALS OY
Profil
Marie-Louise Fjaellskog is currently a Non-Executive Director at Faron Pharmaceuticals Oy and a Director at Lytix Biopharma AS.
She also holds the position of Director at Biovica International AB since 2020 and has been an Associate Professor at the University of Uppsala since 2008.
Previously, she served as Vice President-Clinical Development at Infinity Pharmaceuticals, Inc. from 2018 to 2019 and at Merus NV from 2019 to 2020.
She also worked as the Chief Medical Officer at Sensei Biotherapeutics, Inc. Dr. Fjaellskog holds a doctorate degree from the University of Uppsala.
Postes actifs de Marie-Louise Fjaellskog
Sociétés | Poste | Début |
---|---|---|
FARON PHARMACEUTICALS OY | Director/Board Member | 22/09/2023 |
BIOVICA INTERNATIONAL AB | Director/Board Member | 01/01/2020 |
LYTIX BIOPHARMA | Director/Board Member | - |
University of Uppsala | Corporate Officer/Principal | 01/12/2008 |
Anciens postes connus de Marie-Louise Fjaellskog
Sociétés | Poste | Fin |
---|---|---|
MERUS N.V. | Chief Tech/Sci/R&D Officer | 01/06/2020 |
INFINITY PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
SENSEI BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Marie-Louise Fjaellskog
University of Uppsala | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 6 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
FARON PHARMACEUTICALS OY | Health Technology |
MERUS N.V. | Health Technology |
LYTIX BIOPHARMA | Health Technology |
BIOVICA INTERNATIONAL AB | Health Technology |
SENSEI BIOTHERAPEUTICS, INC. | Health Technology |